Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk
Open Access
- 18 September 2017
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 569
Abstract
MYCN amplification and 11q deletion are two inversely correlated prognostic factors of poor outcome in neuroblastoma. Here we identify common variants at 11q22.2 within MMP20 that associate with neuroblastoma cases harboring 11q deletion (rs10895322), using GWAS in 113 European-American cases and 5109 ancestry-matched controls. The association is replicated in 44 independent cases and 1902 controls. Our study yields novel insights into the genetic underpinnings of neuroblastoma, demonstrating that the inherited common variants reported contribute to the origin of intra-tumor genetic heterogeneity in neuroblastoma.Keywords
This publication has 34 references indexed in Scilit:
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppressionNature Genetics, 2012
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaNature Genetics, 2012
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility LociPLOS Genetics, 2011
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Chromosome 6p22 Locus Associated with Clinically Aggressive NeuroblastomaNew England Journal of Medicine, 2008
- Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaGenes, Chromosomes and Cancer, 2003
- Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasOncogene, 1999